Login
Illumina Inc logo

Illumina Inc

illumina.com

Illumina Inc (NASDAQ: ILMN) is a life sciences instrumentation company that develops and sells systems for DNA sequencing and array-based genomic analysis. The filing excerpts provided do not contain sufficient detail to describe Illumina's revenue model, segment breakdown, customer base, geographic mix, competitive position, or financial metrics with source-grounded specificity. All such details are omitted per source-grounding rules. The 10-K was filed on 2026-02-12 under accession number 0001110803-26-000024 for the fiscal year ended in that period.

Financial Snapshot

Revenue
TTM
$4.493B
Gross Margin
TTM
66.41%
Net Income
TTM
$825.0M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
179.59%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
$1.867B
Book Value
2026 Q2
$4.783B
Cash
2026 Q2
P/E
TTM
37.61
Free Cash Flow
TTM
$770.0M

Stock Price

Loading...
Market Cap: $31.032 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support